SecBot SecBot
SECBOTREPLAY Home › Report › BWXT

BWXT · BWX Technologies has agreed to sell its medical business to Nordic…

Nordic Capital · PRESS-RELEASE filed Aug 3, 2026 at 17:00 ET

At the news

BULLISHIMPACT 6/10

PRESS-RELEASE filed Aug 3, 2026 at 17:00 ET

BWX Technologies has agreed to sell its medical business to Nordic Capital for up to $800 million, retaining a minority stake. The divestiture allows BWXT to refocus capital and resources on its core nuclear national security and commercial nuclear power markets, while the medical business gains a dedicated healthcare investor.

  • BWXT sells its medical business (BWXT Medical and Kinectrics' stable medical isotopes) to Nordic Capital for up to $800 million.
  • BWXT will retain a meaningful minority ownership stake in the divested business.
  • Transaction expected to close by end of 2026, subject to customary regulatory approvals.
  • Sale enables BWXT to concentrate on core nuclear national security and commercial nuclear power growth.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access